Protective Alleles as Public Health Tools

A publicly curated list of genetic variants framed as 'protective' (like CCR5, PCSK9, APOE variants) reframes certain genetic edits or selections from being niche research outputs to actionable public‑health interventions and consumer choices. Making such lists open accelerates uptake by clinics, fertility services, start‑ups, and state actors, with tradeoffs in equity, consent, and biosecurity. — This shifts the debate from abstract ethics to concrete governance: which actors may publish, regulate, or use allele catalogs, and how will society weigh enhancement, risk, and distribution?